| Numero totale di insider | 28 |
Indice del sentiment degli insider
L'indice del sentiment degli insider identifica le società le cui azioni vengono acquistate dagli insider aziendali.
È il risultato di un sofisticato modello quantitativo multi-fattore che identifica le società con i più alti livelli di accumulo di insider. Il modello di punteggio utilizza una combinazione del numero netto di acquisti degli insider negli ultimi 90 giorni, delle azioni totali acquistate in percentuale del flottante e delle azioni totali possedute dagli insider. Il punteggio varia da 0 a 100: i numeri più alti indicano un livello di accumulo superiore ad altre società, mentre 50 rappresenta la media.
Frequenza di aggiornamento: giornaliera
Indice del sentiment dei dirigenti
L'indice del sentiment dei dirigenti identifica le società le cui azioni vengono acquistate dai dirigenti aziendali.
Per definizione, i dirigenti aziendali sono insider della società, ma a differenza di altri insider (azionisti al 10% e membri del consiglio di amministrazione), i dirigenti lavorano quotidianamente per la società e utilizzano il proprio denaro quando fanno trading (gli azionisti al 10% e i membri del consiglio di amministrazione sono spesso gestori di fondi che gestiscono il denaro di altre persone). Pertanto, le operazioni di insider trading effettuate dai dirigenti sono molto più significative e devono essere trattate in modo appropriato.
Come l'indice del sentiment degli insider, l'indice del sentiment dei dirigenti è il risultato di un sofisticato modello quantitativo multi-fattore che identifica le società con i più alti livelli di accumulo di dirigenti.
Frequenza di aggiornamento: giornaliera
Principali indicatori per gli insider
Questa scheda mostra il posizionamento della società in base a diversi indicatori di insider. Il grado percentile mostra come la società si colloca rispetto alle altre società dei mercati statunitensi. Posizioni più alte indicano situazioni migliori.
Ad esempio, è generalmente accettato che gli acquisti di insider siano un indicatore positivo, per cui le società con un maggior numero di acquisti di insider si classificherebbero più in alto rispetto a quelle con un minor numero di acquisti di insider (o addirittura di vendite di insider).
Numero netto di acquisti di insider (classifica)
N/A
Il numero netto di acquisti di insider è il numero totale di acquisti di insider meno il numero totale di vendite di insider negli ultimi 90 giorni. Il grado percentile è mostrato qui (intervallo da 0 a 100%).
Percentuale del flottante acquistato dagli insider (classifica)
N/A
La percentuale del flottante acquistato dagli insider è data dal numero totale di azioni acquistate dagli insider meno il numero totale di azioni vendute dagli insider negli ultimi 90 giorni, divisa per il flottante totale e moltiplicata per 100.
Grafico sull'insider trading
Il grafico seguente mostra le operazioni di insider trading di Surrozen, Inc. - Equity Warrant. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4.
Lista degli insider e indicatori di redditività
Questa tabella mostra la lista degli insider noti ed è generata automaticamente a partire dai depositi effettuati presso la SEC. Oltre ai nomi, al titolo più recente e alla designazione di amministratore, funzionario o proprietario al 10%, forniamo le ultime partecipazioni divulgate. Inoltre, quando possibile, forniamo la performance storica delle transazioni dell'insider. La performance storica delle transazioni è una media ponderata della performance delle operazioni di acquisto sul mercato aperto effettuate dall'insider. Per maggiori informazioni su come viene calcolata, guarda questo webinar su YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Utile medio (%) | Azioni possedute |
Rettificato per il frazionamento azionario |
|---|---|---|---|
|
Mitchell J Md Blutt
10% Owner -
|
0 | 0 | |
| Anna Berkenblit Director - [D] | 35.129 | 2.342 | |
| Christopher Y Chai Director - [D] | 35.129 | 2.342 | |
|
Column Group Iii Gp, Lp
10% Owner -
|
1.361.485 | 1.361.485 | |
|
Column Group Iii, Lp
10% Owner -
|
4.904.884 | 1.361.485 | |
|
Column Group Iii-a, Lp
10% Owner -
|
4.904.884 | 1.361.485 | |
|
Consonance Capital Management LP
Director, 10% Owner -
[D]
|
450.828 | 0 | |
| Consonance Capital Opportunity Fund Management LP Director - [D] | 0 | 128.900 | |
| Consonance Capman GP, LLC Director - [D] | 450.828 | 0 |
| Insider | Utile medio (%) | Azioni possedute |
Rettificato per il frazionamento azionario |
|---|---|---|---|
|
Consonance Life Sciences
10% Owner -
|
1.885.000 | 0 | |
| Mary Haak-Frendscho Director - [D] | 35.129 | 2.342 | |
| Christopher Haqq - | 30.000 | 2.000 | |
| Joshua Cory House | 0 | ||
| Jennifer Jarrett - | 30.000 | 2.000 | |
|
Tim Kutzkey
Director, 10% Owner -
[D]
|
1.361.485 | 1.361.485 | |
| Yang Li Exec. Vice President, Research - [O] | 17.216 | 17.216 | |
| Shao-Lee Lin Director - [D] | 35.129 | 2.342 | |
|
Kevin Harold Livingston
10% Owner -
|
1.885.000 | 0 |
| Insider | Utile medio (%) | Azioni possedute |
Rettificato per il frazionamento azionario |
|---|---|---|---|
| Craig C Parker Chief Executive Officer, Director - [D] [O] | 16.553 | 16.553 | |
| Mace Rothenberg Director - [D] | 35.129 | 2.342 | |
| Donald J Santel - | 30.000 | 2.000 | |
|
Benny Soffer
10% Owner -
|
1.885.000 | 0 | |
| Gad Soffer | 0 | ||
|
TCG Crossover GP II, LLC
10% Owner -
|
736.547 | 736.547 | |
| Geertrui Vanhove Chief Medical Officer - [O] | 32.412 | 2.161 | |
| David J Woodhouse Director - [D] | 35.129 | 2.342 | |
| Charles O Williams Chief Operating Officer - [O] | 16.571 | 16.571 | |
| Wen-Chen Yeh Chief Scientific Officer - [O] | 27.216 | 1.814 |
Report errors via our new Insider Auditing Tool
Storico degli acquisti di insider - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider effettuato sul mercato aperto in SRZNW / Surrozen, Inc. - Equity Warrant. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici .
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Le azioni rettificate sono le azioni rettificate per il frazionamento azionario.
Storico delle vendite di insider - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in SRZNW / Surrozen, Inc. - Equity Warrant. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici .
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Le azioni rettificate sono le azioni rettificate per il frazionamento azionario.
Storico delle transazioni
Clicca sull'icona del link per visualizzare la cronologia completa delle transazioni. Le transazioni segnalate come parte di un piano di trading automatico 10b5-1 saranno contrassegnate con una X nella colonna contrassegnata con 10b-5.
| Data di deposito |
Data dell' operazione |
Modulo | Insider | Ticker | Titolo | Codice | Diretto | Prezzo di esercizio |
Prezzo unitario |
Unità modificate |
Valore modificato (1K) |
Opzioni rimanenti |
Azioni rimanenti |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | 2026-05-04 | 4 | Li Yang | SRZN | Common Stock | D | 33,3328 | -1.584 | -53 | 17.216 | ||||
| 2026-05-05 | 2026-05-01 | 4 | Li Yang | SRZN | Common Stock | D | 4.375 | 18.800 | ||||||
| 2026-05-05 | 2026-05-04 | 4 | Williams Charles O | SRZN | Common Stock | D | 33,3328 | -2.036 | -68 | 16.571 | ||||
| 2026-05-05 | 2026-05-01 | 4 | Williams Charles O | SRZN | Common Stock | D | 5.625 | 18.607 | ||||||
| 2026-05-05 | 2026-05-04 | 4 | Parker Craig C | SRZN | Common Stock | D | 33,3328 | -4.524 | -151 | 16.553 | ||||
| 2026-05-05 | 2026-05-01 | 4 | Parker Craig C | SRZN | Common Stock | D | 12.500 | 21.077 | ||||||
| 2026-04-01 | 2026-03-31 | 4 | Li Yang | SRZN | Common Stock | D | -1.666 | 14.425 | ||||||
| 2026-03-25 | 2026-03-24 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,6931 | 53.329 | 1.317 | 736.547 | ||||
| 2026-03-25 | 2026-03-24 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,6931 | 53.329 | 1.317 | 736.554 | ||||
| 2026-03-25 | 2026-03-23 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8999 | 7.611 | 190 | 683.218 | ||||
| 2026-03-25 | 2026-03-23 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8999 | 7.612 | 190 | 683.225 | ||||
| 2026-03-16 | 2026-03-16 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9857 | 595 | 15 | 675.610 | ||||
| 2026-03-16 | 2026-03-16 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9857 | 595 | 15 | 675.613 | ||||
| 2026-03-16 | 2026-03-13 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8769 | 17.716 | 441 | 675.015 | ||||
| 2026-03-16 | 2026-03-13 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8769 | 17.717 | 441 | 675.018 | ||||
| 2026-03-16 | 2026-03-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9851 | 6.187 | 155 | 657.299 | ||||
| 2026-03-16 | 2026-03-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9851 | 6.187 | 155 | 657.301 | ||||
| 2026-02-13 | 2026-02-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,8625 | 546 | 13 | 651.112 | ||||
| 2026-02-13 | 2026-02-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,8625 | 547 | 13 | 651.114 | ||||
| 2026-02-13 | 2026-02-11 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,5750 | 8.881 | 209 | 650.563 | ||||
| 2026-02-13 | 2026-02-11 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,5750 | 8.882 | 209 | 650.567 | ||||
| 2026-02-03 | 2026-02-03 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,9400 | 2.177 | 48 | 641.682 | ||||
| 2026-02-03 | 2026-02-03 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,9400 | 2.178 | 48 | 641.685 | ||||
| 2026-02-03 | 2026-02-02 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3800 | 365 | 8 | 639.505 | ||||
| 2026-02-03 | 2026-02-02 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3800 | 366 | 8 | 639.507 | ||||
| 2026-02-03 | 2026-01-30 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3900 | 2.135 | 46 | 639.140 | ||||
| 2026-02-03 | 2026-01-30 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3900 | 2.136 | 46 | 639.141 | ||||
| 2026-01-28 | 3 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 637.005 | ||||||||
| 2026-01-28 | 3 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 637.005 | ||||||||
| 2026-01-20 | 2026-01-20 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5999 | 9.568 | 188 | 1.016.658 | ||||
| 2026-01-20 | 2026-01-20 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,5999 | 8.484 | 166 | 900.292 | ||||
| 2026-01-20 | 2026-01-16 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 20,0000 | 1.358 | 27 | 1.007.090 | ||||
| 2026-01-20 | 2026-01-16 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 20,0000 | 1.204 | 24 | 891.808 | ||||
| 2026-01-20 | 2026-01-15 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8890 | 6.303 | 125 | 1.005.732 | ||||
| 2026-01-20 | 2026-01-15 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,8890 | 5.590 | 111 | 890.604 | ||||
| 2026-01-20 | 2026-01-20 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5999 | 9.568 | 188 | 1.016.658 | ||||
| 2026-01-20 | 2026-01-20 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,5999 | 8.484 | 166 | 900.292 | ||||
| 2026-01-20 | 2026-01-16 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 20,0000 | 1.358 | 27 | 1.007.090 | ||||
| 2026-01-20 | 2026-01-16 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 20,0000 | 1.204 | 24 | 891.808 | ||||
| 2026-01-20 | 2026-01-15 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8890 | 6.303 | 125 | 1.005.732 | ||||
| 2026-01-20 | 2026-01-15 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,8890 | 5.590 | 111 | 890.604 | ||||
| 2026-01-15 | 2026-01-14 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,9883 | 2.927 | 59 | 999.429 | ||||
| 2026-01-15 | 2026-01-14 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,9883 | 2.596 | 52 | 885.014 | ||||
| 2026-01-15 | 2026-01-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8041 | 6.609 | 131 | 996.502 | ||||
| 2026-01-15 | 2026-01-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,8041 | 5.861 | 116 | 882.418 | ||||
| 2026-01-15 | 2026-01-14 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,9883 | 2.927 | 59 | 999.429 | ||||
| 2026-01-15 | 2026-01-14 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,9883 | 2.596 | 52 | 885.014 | ||||
| 2026-01-15 | 2026-01-13 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8041 | 6.609 | 131 | 996.502 | ||||
| 2026-01-15 | 2026-01-13 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,8041 | 5.861 | 116 | 882.418 | ||||
| 2026-01-08 | 2026-01-06 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8872 | 8.003 | 159 | 989.893 | ||||
| 2026-01-08 | 2026-01-06 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,8872 | 7.097 | 141 | 876.557 | ||||
| 2026-01-08 | 2026-01-06 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8872 | 8.003 | 159 | 989.893 | ||||
| 2026-01-08 | 2026-01-06 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,8872 | 7.097 | 141 | 876.557 | ||||
| 2026-01-06 | 2026-01-05 | 4 | Li Yang | SRZN | Common Stock | D | 19,8652 | -1.118 | -22 | 16.091 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Li Yang | SRZN | Common Stock | D | 2.500 | 17.209 | ||||||
| 2026-01-06 | 2026-01-05 | 4 | Williams Charles O | SRZN | Common Stock | D | 19,8652 | -1.566 | -31 | 12.982 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Williams Charles O | SRZN | Common Stock | D | 3.500 | 14.548 | ||||||
| 2025-12-16 | 2025-12-15 | 4 | Li Yang | SRZN | Common Stock | D | 8,1100 | 1.666 | 14 | 14.709 | ||||
| 2025-12-16 | 2025-12-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 8,1100 | 1.666 | 14 | 11.048 | ||||
| 2025-12-16 | 2025-12-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 8,1100 | 1.553 | 13 | 8.577 | ||||
| 2025-12-08 | 2025-12-05 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5409 | 16.381 | 320 | 981.890 | ||||
| 2025-12-08 | 2025-12-05 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,5409 | 14.503 | 283 | 869.460 | ||||
| 2025-12-08 | 2025-12-04 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 17,3470 | 2.791 | 48 | 965.509 | ||||
| 2025-12-08 | 2025-12-04 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 17,3470 | 2.475 | 43 | 854.957 | ||||
| 2025-12-08 | 2025-12-05 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5409 | 16.381 | 320 | 981.890 | ||||
| 2025-12-08 | 2025-12-05 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,5409 | 14.503 | 283 | 869.460 | ||||
| 2025-12-08 | 2025-12-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 17,3470 | 2.791 | 48 | 965.509 | ||||
| 2025-12-08 | 2025-12-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 17,3470 | 2.475 | 43 | 854.957 | ||||
| 2025-12-02 | 2025-11-13 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 12,6500 | 167.307 | 2.116 | 962.718 | ||||
| 2025-12-02 | 2025-11-13 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 12,6500 | 148.150 | 1.874 | 852.482 | ||||
| 2025-11-17 | 2025-11-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 12,6500 | 167.307 | 2.116 | 962.718 | ||||
| 2025-11-17 | 2025-11-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 12,6500 | 148.150 | 1.874 | 852.482 | ||||
| 2025-06-16 | 2025-06-13 | 4 | Li Yang | SRZN | Common Stock | D | 8,0600 | 400 | 3 | 13.043 | ||||
| 2025-06-16 | 2025-06-13 | 4 | Williams Charles O | SRZN | Common Stock | D | 8,0600 | 400 | 3 | 9.382 | ||||
| 2025-06-16 | 2025-06-13 | 4 | Parker Craig C | SRZN | Common Stock | D | 8,0600 | 400 | 3 | 7.024 | ||||
| 2025-03-28 | 3 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 795.411 | ||||||||
| 2025-03-28 | 3 | Kutzkey Tim By The Column Group Opportunity III, LP | SRZN | Common Stock | I | 344.827 | ||||||||
| 2025-03-28 | 3 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 704.332 | ||||||||
| 2025-03-28 | 2025-03-26 | 4 | COLUMN GROUP III GP, LP By The Column Group Opportunity III, LP | SRZN | Common Stock | I | 11,6000 | 344.827 | 4.000 | 344.827 | ||||
| 2025-03-28 | 2025-03-26 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 11,6000 | 365.769 | 4.243 | 795.411 | ||||
| 2025-03-28 | 2025-03-26 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 11,6000 | 323.886 | 3.757 | 704.332 | ||||
| 2025-01-06 | 2025-01-03 | 4 | Li Yang | SRZN | Common Stock | D | 17,3700 | -843 | -15 | 13.345 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Li Yang | SRZN | Common Stock | D | 2.500 | 14.188 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Williams Charles O | SRZN | Common Stock | D | 17,3700 | -1.181 | -21 | 8.982 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Williams Charles O | SRZN | Common Stock | D | 3.500 | 10.163 | ||||||
| 2024-06-18 | 2024-06-14 | 4 | Li Yang | SRZN | Common Stock | D | 5,6700 | 400 | 2 | 10.888 | ||||
| 2024-06-18 | 2024-06-14 | 4 | Williams Charles O | SRZN | Common Stock | D | 5,6700 | 400 | 2 | 5.863 | ||||
| 2024-06-18 | 2024-06-14 | 4 | Parker Craig C | SRZN | Common Stock | D | 5,6700 | 400 | 2 | 5.824 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102.651 | 1.591 | 326.992 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90.897 | 1.409 | 289.549 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102.651 | 1.591 | 326.992 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90.897 | 1.409 | 289.549 | ||||
| 2024-04-08 | 2024-04-04 | 4 | Williams Charles O | SRZN | Common Stock | D | 1.474 | 1.474 | ||||||
| 2024-04-08 | 2024-04-04 | 4 | Parker Craig C | SRZN | Common Stock | D | 1.474 | 1.474 | ||||||
| 2024-04-08 | 2024-04-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102.651 | 1.591 | 332.885 | ||||
| 2024-04-08 | 2024-04-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90.897 | 1.409 | 294.767 | ||||
| 2024-04-08 | 2024-04-04 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102.651 | 1.591 | 332.885 | ||||
| 2024-04-08 | 2024-04-04 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90.897 | 1.409 | 294.767 | ||||
| 2023-12-18 | 2023-12-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 5,6700 | 2.085 | 12 | 2.085 | ||||
| 2023-12-18 | 2023-12-15 | 4 | Li Yang | SRZN | Common Stock | D | 5,6700 | 2.085 | 12 | 2.085 | ||||
| 2023-12-18 | 2023-12-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 5,6700 | 2.046 | 12 | 2.046 | ||||
| 2023-08-23 | 3 | Li Yang | SRZN | Common Stock | I | 10.538 | ||||||||
| 2023-08-23 | 3 | Li Yang | SRZN | Common Stock | D | 121.524 | ||||||||
| 2023-06-20 | 2023-06-15 | 4 | Yeh Wen-Chen | SRZN | Common Stock | D | 0,3800 | 17.638 | 7 | 27.216 | ||||
| 2023-06-20 | 2023-06-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 0,3800 | 25.000 | 10 | 34.578 | ||||
| 2023-06-20 | 2023-06-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 0,3800 | 25.000 | 10 | 34.578 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Yeh Wen-Chen | SRZN | Common Stock | D | 0,4100 | 9.578 | 4 | 229.138 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 0,4100 | 9.578 | 4 | 9.578 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Vanhove Geertrui | SRZN | Common Stock | D | 0,4100 | 9.578 | 4 | 32.412 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 0,4100 | 9.578 | 4 | 9.578 | ||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Consonance Life Sciences, LLC | SRZN | Common Stock | I | -1.885.000 | 0 | ||||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Common Stock | I | -450.827 | 0 | ||||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Common Stock | I | -1.297.922 | 0 | ||||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Common Stock | I | -1.748.750 | 0 | ||||||
| 2022-03-03 | 2022-03-01 | 4 | Yeh Wen-Chen | SRZN | Option (right to buy) | D | 3,11 | 125.000 | 125.000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Parker Craig C | SRZN | Stock Option (right to buy) | D | 3,11 | 370.000 | 370.000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Williams Charles O | SRZN | Option (right to buy) | D | 3,11 | 125.000 | 125.000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Vanhove Geertrui | SRZN | Option Grant (right to buy) | D | 3,11 | 3,1100 | 125.000 | 389 | 125.000 | |||
| 2021-08-16 | 3 | COLUMN GROUP III, LP By The Column Group III, LP | SRZN | Common Stock | I | 4.343.245 | ||||||||
| 2021-08-16 | 3 | COLUMN GROUP III, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 4.904.884 | ||||||||
| 2021-08-16 | 3 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 4.343.245 | ||||||||
| 2021-08-16 | 3 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 4.904.884 | ||||||||
| 2021-08-16 | 2021-08-12 | 4 | Parker Craig C | SRZN | Stock Option (right to buy) | D | 10,25 | 183.335 | 183.335 | |||||
| 2021-08-16 | 2021-08-12 | 4 | Vanhove Geertrui | SRZN | Employee Stock Option (right to buy) | D | 10,25 | 36.647 | 36.647 | |||||
| 2021-08-16 | 3 | Vanhove Geertrui | SRZN | Common Stock | D | 22.834 | ||||||||
| 2021-08-16 | 2021-08-12 | 4 | Williams Charles O | SRZN | Employee Stock Option (right to buy) | D | 10,25 | 14.597 | 14.597 | |||||
| 2021-08-16 | 3 | WOODHOUSE DAVID J | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-16 | 3 | Rothenberg Mace | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-16 | 3 | Haak-Frendscho Mary | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-16 | 3 | Berkenblit Anna | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-16 | 3 | Lin Shao-Lee | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-16 | 3 | Yeh Wen-Chen | SRZN | Common Stock | D | 219.560 | ||||||||
| 2021-08-16 | 3 | CHAI CHRISTOPHER Y | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Warrants | I | 11,50 | -144.667 | 144.667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Warrants | I | 11,50 | -144.667 | 0 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Common Stock | I | 1.451.000 | 1.885.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Common Stock | I | 434.000 | 434.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Class B Ordinary Shares | I | -1.451.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Class B Ordinary Shares | I | -759.000 | 1.451.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Class A Ordinary Shares | I | -434.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Jarrett Jennifer | SRZN | Class B Ordinary Shares | D | -30.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Jarrett Jennifer | SRZN | Common Stock | D | 30.000 | 30.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Santel Donald J | SRZN | Class B Ordinary Shares | D | -30.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Santel Donald J | SRZN | Common Stock | D | 30.000 | 30.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Warrants | I | 11,50 | -144.667 | 144.667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Warrants | I | 11,50 | -144.667 | 0 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Common Stock | I | 1.451.000 | 1.885.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Common Stock | I | 434.000 | 434.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Class B Ordinary Shares | I | -1.451.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Class B Ordinary Shares | I | -759.000 | 1.451.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Class A Ordinary Shares | I | -434.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Haqq Christopher | SRZN | Class B Ordinary Shares | D | -30.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Haqq Christopher | SRZN | Common Stock | D | 30.000 | 30.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Warrants | I | 11,50 | -144.667 | 144.667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Warrants | I | 11,50 | -144.667 | 0 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Common Stock | I | 1.451.000 | 1.885.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Common Stock | I | 434.000 | 434.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Class B Ordinary Shares | I | -1.451.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Class B Ordinary Shares | I | -759.000 | 1.451.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Class A Ordinary Shares | I | -434.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Warrants (right to buy) | I | 11,50 | 107.309 | 150.275 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Warrants (right to buy) | I | 11,50 | 308.940 | 432.640 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Warrants (right to buy) | I | 11,50 | 416.250 | 582.917 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Warrants (right to buy) | I | 11,50 | 42.966 | 42.966 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Warrants (right to buy) | I | 11,50 | 123.700 | 123.700 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Warrants (right to buy) | I | 11,50 | 166.667 | 166.667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Common Stock | I | 321.928 | 450.828 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Common Stock | I | 926.822 | 1.297.922 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Common Stock | I | 1.248.750 | 1.748.750 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Common Stock | I | 128.900 | 128.900 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Class A Ordinary Shares | I | -128.900 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Common Stock | I | 371.100 | 371.100 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Class A Ordinary Shares | I | -371.100 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Common Stock | I | 500.000 | 500.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Class A Ordinary Shares | I | -500.000 | 0 | ||||||
| 2021-05-19 | 2020-11-23 | 4/A | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 136.667 | 136.667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 410.000 | 410.000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0109 | -30.000 | -0 | 2.240.000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | -575.000 | 2.300.000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | -718.750 | 2.875.000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0070 | 3.593.750 | 25 | 3.593.750 | ||||
| 2021-05-19 | 2020-12-01 | 4/A | Soffer Benny | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | Soffer Benny | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2021-05-19 | 2020-11-23 | 4/A | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.240.000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | -575.000 | 2.300.000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | -718.750 | 2.875.000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0070 | 3.593.750 | 25 | 3.593.750 | ||||
| 2021-05-19 | 2020-11-23 | 4/A | Soffer Benny | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | Soffer Benny | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.240.000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | -575.000 | 2.300.000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | -718.750 | 2.875.000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0070 | 3.593.750 | 25 | 3.593.750 | ||||
| 2021-05-19 | 2020-12-01 | 4/A | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 8.000 | 144.667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 24.000 | 434.000 | ||||||
| 2021-05-19 | 2020-12-01 | 4/A | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2021-05-19 | 2020-11-23 | 4/A | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.240.000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | -575.000 | 2.300.000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | -718.750 | 2.875.000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0070 | 3.593.750 | 25 | 3.593.750 | ||||
| 2021-05-19 | 2020-12-01 | 4/A | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2021-05-19 | 3/A | BLUTT MITCHELL J MD Consonance Life Sciences, LLC | CHFW | Class B Ordinary Shares | I | 2.210.000 | ||||||||
| 2021-05-19 | 3/A | Soffer Benny Consonance Life Sciences, LLC | CHFW | Class B Ordinary Shares | I | 2.210.000 | ||||||||
| 2021-05-19 | 3/A | Livingston Kevin Harold Consonance Life Sciences, LLC | CHFW | Class B Ordinary Shares | I | 2.210.000 | ||||||||
| 2021-05-19 | 3/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 2.210.000 | ||||||||
| 2020-12-04 | 2020-11-23 | 4 | BLUTT MITCHELL J MD By Managed Account | CHFW | Class A Ordinary Shares | I | 128.900 | 128.900 | ||||||
| 2020-12-04 | 2020-11-23 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | CHFW | Class A Ordinary Shares | I | 371.100 | 371.100 | ||||||
| 2020-12-04 | 2020-11-23 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account, LP | CHFW | Class A Ordinary Shares | I | 500.000 | 500.000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 8.000 | 144.667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 24.000 | 434.000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | Soffer Benny | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Soffer Benny | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 136.667 | 136.667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 410.000 | 410.000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Soffer Benny | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Soffer Benny | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 |
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)
